These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 31100311)

  • 1. Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer.
    Li M; Xie H; Liu Y; Xia C; Cun X; Long Y; Chen X; Deng M; Guo R; Zhang Z; He Q
    J Control Release; 2019 Jun; 304():204-215. PubMed ID: 31100311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer.
    Wei H; Li F; Fu P; Liu X
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):436-46. PubMed ID: 23467940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antisense hypoxia-inducible factor 1alpha on progression, metastasis, and chemosensitivity of pancreatic cancer.
    Chang Q; Qin R; Huang T; Gao J; Feng Y
    Pancreas; 2006 Apr; 32(3):297-305. PubMed ID: 16628086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer.
    Niu Y; Jin Y; Deng SC; Deng SJ; Zhu S; Liu Y; Li X; He C; Liu ML; Zeng Z; Chen HY; Zhong JX; Ye Z; Wang CY; Zhao G
    Oncogene; 2018 Mar; 37(13):1743-1758. PubMed ID: 29343850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal loop of hypoxia-inducible factor-1α (HIF-1α) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription.
    Zhu S; Deng S; He C; Liu M; Chen H; Zeng Z; Zhong J; Ye Z; Deng S; Wu H; Wang C; Zhao G
    J Pathol; 2018 Jul; 245(3):349-360. PubMed ID: 29708271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
    Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
    Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of HIF-1α Knockout Primary Human Natural Killer Cells Including Populations in Allogeneic Glioblastoma.
    Nakazawa T; Morimoto T; Maeoka R; Yamada K; Matsuda R; Nakamura M; Nishimura F; Yamada S; Park YS; Tsujimura T; Nakagawa I
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L: -ascorbate on pancreatic tumors in athymic mice.
    Chen C; Sun J; Liu G; Chen J
    Pathol Oncol Res; 2009 Mar; 15(1):109-14. PubMed ID: 18509748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
    Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
    Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic ascorbate (P-AscH
    Wilkes JG; O'Leary BR; Du J; Klinger AR; Sibenaller ZA; Doskey CM; Gibson-Corley KN; Alexander MS; Tsai S; Buettner GR; Cullen JJ
    Clin Exp Metastasis; 2018 Feb; 35(1-2):37-51. PubMed ID: 29396728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
    Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
    Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salidroside ameliorated hypoxia-induced tumorigenesis of BxPC-3 cells via downregulating hypoxia-inducible factor (HIF)-1α and LOXL2.
    Chen X; Kou Y; Lu Y; Pu Y
    J Cell Biochem; 2020 Jan; 121(1):165-173. PubMed ID: 31162697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RER1 enhances carcinogenesis and stemness of pancreatic cancer under hypoxic environment.
    Chen S; Zhang J; Chen J; Wang Y; Zhou S; Huang L; Bai Y; Peng C; Shen B; Chen H; Tian Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):15. PubMed ID: 30630537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein.
    Liu M; Zhong J; Zeng Z; Huang K; Ye Z; Deng S; Chen H; Xu F; Li Q; Zhao G
    Theranostics; 2019; 9(16):4795-4810. PubMed ID: 31367258
    [No Abstract]   [Full Text] [Related]  

  • 15. LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α.
    Zeng Z; Xu FY; Zheng H; Cheng P; Chen QY; Ye Z; Zhong JX; Deng SJ; Liu ML; Huang K; Li Q; Li W; Hu YH; Wang F; Wang CY; Zhao G
    Theranostics; 2019; 9(18):5298-5314. PubMed ID: 31410216
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells.
    He X; Wang J; Wei W; Shi M; Xin B; Zhang T; Shen X
    Cancer Biol Ther; 2016; 17(2):188-98. PubMed ID: 26785721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
    Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
    J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression.
    Gao C; Li S; Zhao T; Chen J; Ren H; Zhang H; Wang X; Lang M; Liu J; Gao S; Zhao X; Sheng J; Yuan Z; Hao J
    PLoS One; 2015; 10(3):e0121338. PubMed ID: 25799412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.
    Chintala S; Tóth K; Cao S; Durrani FA; Vaughan MM; Jensen RL; Rustum YM
    Cancer Chemother Pharmacol; 2010 Oct; 66(5):899-911. PubMed ID: 20066420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTA1 promotes the invasion and migration of pancreatic cancer cells potentially through the HIF-α/VEGF pathway.
    Sun X; Zhang Y; Li B; Yang H
    J Recept Signal Transduct Res; 2018 Aug; 38(4):352-358. PubMed ID: 30396299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.